Pharmaceutical PV DIV - FSB
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- SPE2DR25D9329
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Task orders
- 173 $2,329,928 obligated
Award facts
- Opportunity
-
- Pharmaceutical Prime Vendor Global GEN V Presolicitation Pre-Solicitation · SPE2DX24R0001 · Posted Feb 1, 2024
- Combined order value
- $2,329,928 Current and potential, with all options
- Last date to order 9% complete
- IDV ceiling 47% used
- $4,999,999.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The federal contract IDV awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, is for the provision of a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans' medical centers nationwide. The $4,999,999 single-award Indefinite Delivery Contract (IDC) covers an extensive portfolio of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across various product categories such as injections, tablets, creams, auto-injectors, and specialty medications.
The original solicitation, the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), aims to establish multiple regional prime vendor contracts to provide worldwide pharmaceutical support to the Defense Health Agency (DHA), Department of Defense (DoD) customers, the United States Coast Guard, Designated Providers, Other Government Agencies, and the US Naval Fleet. The $30.3 billion acquisition is structured as a firm-fixed-price, requirements-type contract with a 30-month base period and three 30-month option periods, awarded on a lowest price technically acceptable basis. The contract will enable the DLA to issue delivery orders for a diverse array of pharmaceutical products to support normal day-to-day operations, planned and unplanned contingency, Prime Vendor Readiness (PVR), and War Readiness Materiel (WRM) requirements at both CONUS and OCONUS locations.
Task orders
Show 40 more
Latest 50 of 173 listed here. See the rest on GovTribe.
Quick answers
Who was awarded contract SPE2DR25D9329?
SPE2DR25D9329 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 13, 2025.
How much is contract SPE2DR25D9329 worth?
Orders under SPE2DR25D9329 have obligated $2,329,928. SPE2DR25D9329's own ceiling is $4,999,999.
How many orders have been placed under contract SPE2DR25D9329?
173 orders have been placed under SPE2DR25D9329, the latest on July 28, 2026.
Who can order from contract SPE2DR25D9329?
SPE2DR25D9329 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract SPE2DR25D9329 competed?
The extent of competition for SPE2DR25D9329 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV